LNSR
LENSAR, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.94
+6.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 281.50x
- P/S forward
- 1.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.68x
- PEG TTM
- —
- Price / book
- 4.90x
- Price / sales
- 1.21x
- Price / cash flow
- -10.01x
Enterprise value
- Enterprise value
- $61.8M
- EV / sales
- 1.03x
- EV / EBITDA
- 1.69x
- EV / EBIT
- -7.60x
- Market cap
- $73.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026